iX Syrinx
- Company typePrivate
- Founded-
- HeadquartersCroydon, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
iX Syrinx firmographics
Firmographics- Name
- iX Syrinx
- Website
- https://ixsyrinx.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
iX Syrinx industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medical Laboratories (621511)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)
Keywords
Where iX Syrinx is headquartered
LocationHeadquarters
- HQ city
- Croydon
- HQ country
- Australia
- HQ region
- Oceania
Markets served
iX Syrinx business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
iX Syrinx product offering
Product offeringCore offering
iX Syrinx is a pharmaceutical manufacturer that delivers formulation development, analytical testing, contract manufacturing, and pharmaceutical consultation services. The company operates from Croydon, Australia, and serves external business clients in the pharmaceutical sector. It functions as a contract service provider rather than a finished-drug product brand.
Differentiator
Problem solved
Functional benefit
Products and services
- Formulation Development
Companies that use iX Syrinx
Customer profileIdeal customer profiles1 record
iX Syrinx technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
iX Syrinx competitors and assessment
Company assessmentBroad incumbents
- PCI Pharma Services: Integrated CDMO providing formulation, analytical, and contract manufacturing services for pharma sponsors; competes with iX Syrinx for outsourced development and commercial supply work.
- Lonza Group: Global CDMO with integrated development, manufacturing, and analytical services for small molecules and biologics; comparable to iX Syrinx's integrated service stack but at vastly larger scale and geographic reach.
- CordenPharma: Full-service CDMO providing API and drug product development, analytical services, and contract manufacturing — closely comparable integrated offering to iX Syrinx, though at significantly larger scale.
- Catalent: Large global CDMO offering formulation development, analytical services, and contract manufacturing across multiple dosage forms — a broad incumbent against which iX Syrinx competes for outsourced pharma development and manufacturing work.
- Thermo Fisher Scientific (Patheon CDMO): Through its Patheon CDMO business, Thermo Fisher offers end-to-end pharmaceutical development, analytical, and contract manufacturing services globally — a broad incumbent directly overlapping iX Syrinx's integrated service model.
- Recipharm: European-headquartered CDMO offering formulation development, analytical services, and contract manufacturing across multiple therapeutic categories; directly comparable integrated CDMO model to iX Syrinx.
Direct peers
- IDT Australia: Australian pharmaceutical manufacturer providing contract manufacturing, formulation development, and analytical services to local and international sponsors — a direct regional peer with overlapping CDMO capabilities.
- Luina Bio: Australian-based biopharmaceutical contract manufacturer offering process development, analytical, and GMP manufacturing services; a directly comparable regional CDMO peer operating from Australia.
- BioCina: Australia-based CDMO offering microbial fermentation, analytical, and contract manufacturing services for biologics and small molecules; a relevant regional CDMO peer to iX Syrinx in the Australian market.
- Ardena: Specialty CDMO focused on formulation development, analytical chemistry, and small-batch GMP manufacturing for early-stage and specialty pharma — a highly comparable niche CDMO peer to iX Syrinx's integrated service profile.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights3 records
Customer concentration
iX Syrinx financial estimates
Financial estimateRevenue estimate
Valuation estimate
iX Syrinx leadership team
Management profileNumber of profiles
iX Syrinx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
iX Syrinx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about iX Syrinx
What does iX Syrinx do?
iX Syrinx is a pharmaceutical manufacturer that delivers formulation development, analytical testing, contract manufacturing, and pharmaceutical consultation services. The company operates from Croydon, Australia, and serves external business clients in the pharmaceutical sector. It functions as a contract service provider rather than a finished-drug product brand.
Is iX Syrinx a public or private company?
iX Syrinx is a private company. It is classified as unknown and is currently operating.
When was iX Syrinx founded?
iX Syrinx was founded in -1. It employs 11 to 50 people.
Where is iX Syrinx based?
iX Syrinx is headquartered in Croydon, Australia, in the Oceania region.
Who are iX Syrinx's main competitors?
Broad incumbents on record are PCI Pharma Services, Lonza Group, CordenPharma, Catalent, Thermo Fisher Scientific (Patheon CDMO) and Recipharm. Direct peers are IDT Australia, Luina Bio, BioCina and Ardena.
Does iX Syrinx have an API?
No public API is recorded for iX Syrinx.
What industry is iX Syrinx in?
iX Syrinx's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 325412 and its SIC code is 2834.